20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      α-Glucosidase inhibition by flavonoids: an in vitro and in silico structure–activity relationship study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          α-Glucosidase inhibitors are described as the most effective in reducing post-prandial hyperglycaemia (PPHG) from all available anti-diabetic drugs used in the management of type 2 diabetes mellitus. As flavonoids are promising modulators of this enzyme’s activity, a panel of 44 flavonoids, organised in five groups, was screened for their inhibitory activity of α-glucosidase, based on in vitro structure–activity relationship studies. Inhibitory kinetic analysis and molecular docking calculations were also applied for selected compounds. A flavonoid with two catechol groups in A- and B-rings, together with a 3-OH group at C-ring, was the most active, presenting an IC 50 much lower than the one found for the most widely prescribed α-glucosidase inhibitor, acarbose. The present work suggests that several of the studied flavonoids have the potential to be used as alternatives for the regulation of PPHG.

          Abstract

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes.

          This paper describes the development of a simple empirical scoring function designed to estimate the free energy of binding for a protein-ligand complex when the 3D structure of the complex is known or can be approximated. The function uses simple contact terms to estimate lipophilic and metal-ligand binding contributions, a simple explicit form for hydrogen bonds and a term which penalises flexibility. The coefficients of each term are obtained using a regression based on 82 ligand-receptor complexes for which the binding affinity is known. The function reproduces the binding affinity of the complexes with a cross-validated error of 8.68 kJ/mol. Tests on internal consistency indicate that the coefficients obtained are stable to changes in the composition of the training set. The function is also tested on two test sets containing a further 20 and 10 complexes, respectively. The deficiencies of this type of function are discussed and it is compared to approaches by other workers.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis

            Type 2 diabetes is the most prevalent and serious metabolic disease all over the world, and its hallmarks are pancreatic β-cell dysfunction and insulin resistance. Under diabetic conditions, chronic hyperglycemia and subsequent augmentation of reactive oxygen species (ROS) deteriorate β-cell function and increase insulin resistance which leads to the aggravation of type 2 diabetes. In addition, chronic hyperglycemia and ROS are also involved in the development of atherosclerosis which is often observed under diabetic conditions. Taken together, it is likely that ROS play an important role in the development of type 2 diabetes and atherosclerosis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of alpha-glucosidase.

              Three flavonoids from tartary buckwheat bran, namely, quercetin (Que), isoquercetin (Iso) and rutin (Rut), have been evaluated as alpha-glucosidase inhibitors by fluorescence spectroscopy and enzymatic kinetics and have also been compared with the market diabetes healer, acarbose. The results indicated that Que, Iso and Rut could bind alpha-glucosidase to form a new complex, which exhibited a strong static fluorescence quenching via nonradiation energy transfer, and an obvious blue shift of maximum fluorescence. The sequence of binding constants (K(A)) was Que > Iso > Rut, and the number of binding sites was one for all of the three cases. The thermodynamic parameters were obtained by calculations based on data of binding constants. They revealed that the main driving force of the above-mentioned interaction was hydrophobic. Enzymatic kinetics measurements showed that all of the three compounds were effective inhibitors against alpha-glucosidase. Inhibitory modes all belonged to a mixed type of noncompetitive and anticompetitive. The sequence of affinity (1/K(i)) was in accordance with the results of binding constants (K(A)). The concentrations which gave 50% inhibition (IC(50)) were 0.017 mmol*L(-1), 0.185 mmol*L(-1) and 0.196 mmol*L(-1), compared with acarbose's IC(50) (0.091 mmol*L(-1)); the dose of acarbose was almost five times of that of Que and half of that of Iso and Rut. Our results explained why the inhibition on alpha-glucosidase of tartary buckwheat bran extractive substance (mainly Rut) was much weaker than that of its hydrolysis product (a mixture of Que, Iso and Rut). This work would be significant for the development of more powerful antidiabetes drugs and efficacious utilization of tartary buckwheat, which has been proved as an acknowledged food in the diet of diabetic patients.
                Bookmark

                Author and article information

                Journal
                J Enzyme Inhib Med Chem
                J Enzyme Inhib Med Chem
                IENZ
                ienz20
                Journal of Enzyme Inhibition and Medicinal Chemistry
                Taylor & Francis
                1475-6366
                1475-6374
                2017
                21 September 2017
                : 32
                : 1
                : 1216-1228
                Affiliations
                [a ] UCIBIO, REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto , Porto, Portugal;
                [b ] UCIBIO, REQUIMTE, Faculty of Sciences, Department of Chemistry and Biochemistry, University of Porto , Porto, Portugal;
                [c ] Department of Chemistry & QOPNA, University of Aveiro , Aveiro, Portugal
                Author notes

                Supplemental data for this article can be accessed here .

                CONTACT Eduarda Fernandes egracas@ 123456ff.up.pt UCIBIO, REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto , Porto, Portugal;
                Pedro A. Fernandes pafernan@ 123456fc.up.pt UCIBIO, REQUIMTE, Faculty of Sciences, Department of Chemistry and Biochemistry, University of Porto , Porto, Portugal
                Author information
                http://orcid.org/0000-0001-6424-0976
                Article
                1368503
                10.1080/14756366.2017.1368503
                6009965
                28933564
                01d89db0-1687-482d-8a05-63e4154d4501
                © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 31 May 2017
                : 27 July 2017
                : 04 August 2017
                Page count
                Pages: 13, Words: 9082
                Funding
                Funded by: Fundação para a Ciência e Tecnologia and Ministério da Educação e Ciência 10.13039/501100001871
                Funded by: European Union funds
                Award ID: PT2020 UID/MULTI/04378/2013 – POCI/01/0145/FEDER/007728
                Award ID: FCT UID/QUI/00062/2013
                Award ID: NORTE-01–0145-FEDER-000024
                Funded by: Programa Operacional Competitividade e Internacionalização
                Award ID: PTDC/QEQ-QAN/1742/2014 – POCI-01–0145-FEDER-016530
                Funded by: FCT 10.13039/100006136
                Award ID: SFRH/BD/116005/2016
                Funded by: Fundo Social Europeu
                Funded by: Ministério da Ciência, Tecnologia e Ensino Superior 10.13039/501100006111
                The authors acknowledge the financial support from National funds [Fundação para a Ciência e Tecnologia and Ministério da Educação e Ciência (FCT/MEC)] and European Union funds [Fundo Europeu de Desenvolvimento Regional (FEDER)] under the program PT2020 (PT2020 UID/MULTI/04378/2013 - POCI/01/0145/FEDER/007728), the framework of QREN (NORTE-01-0145-FEDER-000024), and Programa Operacional Competitividade e Internacionalização (COMPETE). Carina Proença acknowledges FCT the financial support for the PhD grant (SFRH/BD/116005/2016), in the ambit of “QREN - POPH - Tipologia 4.1 - Formação Avançada”, co-sponsored by Fundo Social Europeu (FSE) and by national funds of Ministério da Ciência, Tecnologia e Ensino Superior (MCTES). Daniela Ribeiro acknowledges FEDER, through COMPETE and FCT, the financial support for the Post-doc grant in the ambit of the project PTDC/QEQ-QAN/1742/2014 - POCI-01-0145-FEDER-016530.
                Categories
                Research Paper

                Pharmaceutical chemistry
                diabetes,flavonoids,α-glucosidase inhibition,in vitro,in silico
                Pharmaceutical chemistry
                diabetes, flavonoids, α-glucosidase inhibition, in vitro, in silico

                Comments

                Comment on this article